ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
U.S. Food and Drug Administration (FDA) Accepts Application for Opdivo Plus Low-Dose Yervoy for Treatment of First-Line Non-Small Cell Lung Cancer in Patients with Tumor Mutational Burden =10 mut/Mb
americanpharmaceuticalreview
June 27, 2018ristol-Myers Squibb Company?(NYSE: BMY) announced today that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for?Opdivo?(nivolumab) plus low -
FDA Approves Epidiolex
drugs
June 26, 2018The U.S. Food and Drug Administration today approved?Epidiolex?(cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy -
FDA Approves Retacrit
drugs
May 17, 2018The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease
Pharma Sources Insight January 2025
